on the other hand , if the physiological steady state levels of ado are maintained by collecting the blood in the presence of the inhibitors of ada ( 2'-deoxycoformycin , dcf , 5 microm ) and ado uptake ( dipyridamole , 10 microm or dilazep , 2 microm ) , forskolin inhibition ( ic50 , 3.2 microm ) on platelet aggregation in human prp is potentiated by 20-40 fold ( ic50 , 0.075-0.15 microm ) .
C1373051
inhibitors
C0012582
dipyridamole